Neuromuscular doseresponse studies: Determining sample size

British Journal of Anaesthesia

Volumn 106, Issue 2, 2011, Pages 194-198

  Kopman, A F ^a   Lien, C A ^a   Naguib, M ^b  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

neuromuscular block; pharmacology, dose response; potency, drug; power analysis

Indexed keywords

ATRACURIUM; CISATRACURIUM; NEUROMUSCULAR BLOCKING AGENT; PANCURONIUM; PIPECURONIUM; RAPACURONIUM BROMIDE; ROCURONIUM; SUXAMETHONIUM; VECURONIUM;

ACCURACY; ARTICLE; DOSE RESPONSE; NEUROMUSCULAR BLOCKING; PRIORITY JOURNAL; SAMPLE SIZE; SINGLE DRUG DOSE; ADULT; DRUG EFFECT; HUMAN; METHODOLOGY; NEUROMUSCULAR SYNAPSE; PHYSIOLOGY; RETROSPECTIVE STUDY;

ADULT; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; NEUROMUSCULAR BLOCKADE; NEUROMUSCULAR BLOCKING AGENTS; NEUROMUSCULAR JUNCTION; RESEARCH DESIGN; RETROSPECTIVE STUDIES; SAMPLE SIZE;

EID: 78751499385     PISSN: 00070912     EISSN: 14716771     Source Type: Journal    
DOI: 10.1093/bja/aeq310     Document Type: Article

References (13)

1. Katz RL. Neuromuscular effects of d-tubocurarine, edrophonium, and neostigmine in man. Anesthesiology 1967; 28: 327-36
2. Dahaba AA, Perelman SI, Moskowitz DM, et al. Geographic regional differences in rocuronium bromide dose-response relation and time course of action: an overlooked factor in determining recommended dosage. Anesthesiology 2006; 104: 950-3
3. Fuchs-Buder T, Claudius C, Skovgaard LT, et al. Good clinical research practice in pharmacodynamic studies of neuromuscular blocking agents II: the Stockholm revision. Acta Anaesthesiol Scand 2007; 51: 789-808
4. Claudius C, Skovgaard LT, Viby-Mogensen J. Acceleromyography and mechanomyography for establishing potency of neuromuscular blocking agents: a randomized-controlled trial. Acta Anaesthesiol Scand 2009; 53: 449-54
5. Kopman AF, Klewicka MM, Neuman GG. An alternate method for estimating the dose-response relationships of neuromuscular blocking drugs. Anesth Analg 2000; 90: 1191-7
6. Kopman AF, Klewicka MM, Ghori K, et al. Dose-response and onset/offset characteristics of rapacuronium. Anesthesiology 2000; 93: 1017-21
7. Kopman AF, Lien CA, Naguib M. Determining the potency of neuromuscular blockers: are traditional methods flawed? Br J Anaesth 2010; 104: 705-10
8. Naguib M, Samarkandi AH, Amnar A, Al-Zahrani S. Comparative clinical pharmacology of rocuronium, cisatracurium, and their combination. Anesthesiology 1998; 89: 1116-24.
9. Naguib M, Samarkandi AH, Bakhamees HS, et al. Comparative potency of steroidal neuromuscular blocking drugs and isobolographic analysis of the interaction between rocuronium and other aminosteroids. Br J Anaesth 1995; 75: 37-42
10. Faul F, Erdfelder E, Lang A, Buchner A. G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods 2007; 39: 175-91
11. Lebrault C, Chauvin M, Guirimand F, Duvaldestin P. Relative potency of vecuronium on the diaphragm and the adductor pollicis. Br J Anaesth 1989; 63: 389-92
12. Meretoja OA, Wirtavuori K. Two-dose technique to create an individual dose-response curve for atracurium. Anesthesiology 1989; 70: 732-6
13. Oris B, Crul JF, Vandermeersch E, Van Aken H, Van Egmond J, Sabbe MB. Muscle paralysis by rocuronium during halothane, enflurane, isoflurane, and total intravenous anesthesia. Anesth Analg 1993; 77: 570-3